July 20th- Beyond the Webinar: Are CALR-Directed Therapies Redefining the Future of Myeloproliferative Neoplasms? CME Congresses . July 20th- Beyond the Webinar: Are CALR-Directed Therapies Redefining the Future of Myeloproliferative Neoplasms? July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma CME Congresses . July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility CME Congresses . July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility July 9th- Beyond the Webinar: EBV Infection After Allogeneic Stem Cell Transplantation – From Viral Monitoring to Precision Cellular Therapy CME Congresses . July 9th- Beyond the Webinar: EBV Infection After Allogeneic Stem Cell Transplantation – From Viral Monitoring to Precision Cellular Therapy July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship CME Congresses . July 6th- Beyond the Webinar: Fertility After CAR-T Cell Therapy: Moving Beyond Survival Toward Survivorship July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma? CME Congresses . July 2nd- MajesTEC-5: Is Teclistamab Moving to the Frontline of Multiple Myeloma? June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology CME Congresses . June 25th- Beyond the webinar: VEXAS Syndrome: When Inflammation Becomes Clonal Hematology June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads CME Congresses . June 19th- Post-ASCO and EHA 2026: Multiple Myeloma at the Immunotherapy Crossroads June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL? CME Congresses . June 22nd- Can an All-Oral Combination Change the Treatment Landscape of Relapsed/Refractory DLBCL? June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? CME Congresses . June 14th- LIVE from #EHA26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24
